ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500660 announcements Glaxosmith announcements and dividends declared BSE

Glaxosmith Complete list of announcements declared & dividend announcements by Glaxosmith 500660

Glaxosmith 500660 listed on BSE and deals in

Announcements and dividends declared by Glaxosmith 500660

GlaxoSmithKline Pharma Q3 profit up 29 pc at Rs 296 cr
GlaxoSmithKline Pharmaceuticals on Monday posted 29 per cent increase in consolidated profit after tax at Rs 296 crore for the third quarter ended December 31, 2025. The drugmaker reported a profit after tax of Rs 230 crore for the October-December period
Announcement as on 09 February 2026

Breakout Stocks: How to trade JK Cement, AstraZeneca Pharma & GlaxoSmithKline Pharma that hit 52-week high?
Indian stock markets ended a 7-day rally amid global cues. Stocks like JK Cement, AstraZeneca Pharma, and GlaxoSmithKline Pharma showed strong momentum, with analysts suggesting bullish targets and key support levels.
Announcement as on 24 April 2025

I-Sec upgrades GlaxoSmithKline Pharma to Add, lowers target price to Rs 2,250
ICICI Securities has raised its rating on GlaxoSmithKline Pharmaceuticals to Add from Hold with a new target price of Rs 2250. GSK Pharma's earnings are expected to see a CAGR of 15.3% over FY24-27. The company has an asset-light and cash-rich balance shee
Announcement as on 19 February 2025

Glaxosmithkline Breaks Below 200-Day Moving Average - Notable for GLAXF
In trading on Tuesday, shares of Glaxosmithkline plc (Symbol: GLAXF) crossed below their 200 day moving average of .46, changing hands as low as .18 per share. Glaxosmithkline plc shares are currently trading down about 1.4% on the day. The chart b
Announcement as on 24 September 2024

HUL slapped with Rs 962 crore tax notice over TDS dispute in Rs 3,045 crore GlaxoSmithKline deal
Hindustan Unilever has received a tax demand of Rs 962.75 crore from the Income Tax Department over non-deduction of TDS for acquiring intellectual property rights from GlaxoSmithKline. The company intends to appeal the order and claims it has a right to r
Announcement as on 27 August 2024

Announcements by Glaxosmith first page | Next page |

500660 Glaxosmith current price & indicator signals

Moving Averages for Glaxosmith

  • 5Day Average: 2503.06
  • 12Day Average: 2539.73
  • 20Day Average: 2566.74
  • 50Day Average: 2479.19
  • 100Day Average: 2521.7
  • 150Day Average: 2599.9
  • 200Day Average: 2760.58

500660 Indicators & signals

Indicator MACD (12,26,9)

2524.84, 2527.07, 13.71
Indicator MACD is in negative zone

Indicator ADX (14)

9.87, 16.26, 19.82
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500660 Glaxosmith are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
12 Thu Mar 2026 2504.15 2434.55 to 2517.20 0.76% 2.39 times
11 Wed Mar 2026 2485.15 2472.65 to 2540.00 -0.26% 1.2 times
10 Tue Mar 2026 2491.55 2480.10 to 2555.00 -1.2% 1.16 times
09 Mon Mar 2026 2521.70 2452.85 to 2532.40 0.36% 2.52 times
06 Fri Mar 2026 2512.75 2445.00 to 2528.05 1.4% 0.43 times
05 Thu Mar 2026 2478.10 2451.00 to 2520.40 -0.17% 0.81 times
04 Wed Mar 2026 2482.40 2479.45 to 2507.50 -2.11% 1.13 times
02 Mon Mar 2026 2535.90 2511.70 to 2578.90 -1.33% 0.71 times
27 Fri Feb 2026 2570.00 2566.10 to 2611.60 -2.09% 0.41 times
26 Thu Feb 2026 2624.85 2611.00 to 2646.85 -0.98% 0.5 times
25 Wed Feb 2026 2650.85 2597.05 to 2665.00 1.2% 1.11 times
24 Tue Feb 2026 2619.40 2591.60 to 2693.65 -0.68% 0.49 times

Videos related to: 500660 announcements Glaxosmith announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500660 announcements Glaxosmith announcements and dividends declared BSE

 

Back to top